Related Experiment Video
Updated: Dec 21, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Do-it-yourself closed-loop systems for people living with type 1 diabetes.
L Dowling1, E G Wilmot2, P Choudhary3
1Diabetes UK, London, UK.
Summary
People with type 1 diabetes are using do-it-yourself closed-loop systems, reporting benefits like improved HbA1c. Healthcare professionals should discuss risks and benefits but cannot recommend these unapproved systems.
Area of Science:
- Endocrinology
- Medical Technology
- Diabetes Management
Background:
- Increasing adoption of do-it-yourself (DIY) closed-loop systems by individuals with type 1 diabetes.
- Users report positive outcomes including improved HbA1c, enhanced time in range, and reduced diabetes management burden.
- Regulatory and legal concerns exist for healthcare professionals supporting unapproved technologies.
Purpose of the Study:
- To provide guidance for people with type 1 diabetes and healthcare professionals regarding DIY closed-loop systems.
- To address the professional and legal implications of using non-commercial, unapproved diabetes technologies.
- To outline recommendations for supporting informed decision-making and continued care.
Main Methods:
- Review of current professional and legal landscape concerning DIY diabetes technology.
- Development of position statements and recommendations by Diabetes UK.
- Emphasis on open communication and balanced risk-benefit discussions between patients and healthcare providers.
Main Results:
- Recognition of individuals' right to make informed decisions about diabetes management.
- Recommendation for continued support and care from diabetes teams for DIY system users.
- Inability of healthcare professionals to formally recommend DIY systems due to lack of regulatory approval and published safety data.
Conclusions:
- DIY closed-loop systems offer reported benefits but carry inherent risks for users.
- Healthcare professionals must engage in informed discussions but cannot endorse unapproved technologies.
- There is a need for professional and regulatory guidance in the rapidly evolving field of diabetes technology.
More Related Videos
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
781
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
781
01:17Open and closed-loop control systems
1.4K
Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
1.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:36Carbohydrate Metabolism
13.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K
01:01Feedback Loops
63.3K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
63.3K
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K